Live Streaming Giant Dumps Short Drama Unit for AI Bet, While MedTech Rival Nails FDA Trial Green LightGlobal Report·Oct 24, 2026 at 09:13 AM03700-2.78%09877+2.13%
Jenscare (9877.HK) climbs 4% on NMPA approval, strong resultsHK Stock Market Update·Oct 7, 2026 at 02:17 AM09877+2.13%
Jenscare Wins NMPA Approval for JensClip, Accelerates Global Valve Portfolio PushTip Ranks·Sep 22, 2026 at 11:42 AM09877+2.13%
Jenscare says LuX-Valve Plus wins Hong Kong health regulator approvalPUBT·Sep 4, 2026 at 02:48 PM09877+2.13%
Jenscare FY26 H1 net loss narrows 71.4% to RMB 48.76 million; revenue rises 377.7% to RMB 64.13 millionPUBT·Aug 31, 2026 at 01:03 PM09877+2.13%